Abstract:Fulminant hepatic failure is infrequently seen as a consequence of acute congestive heart failure. Recognition of this entity is important as treatment directed towards heart failure should help resolve the liver failure. A case of fulminant hepatic failure due to previously unrecognized cardiomyopathy is presented. A liver transplantation was being considered for fulminant hepatic failure until hemodynamic monitoring studies demonstrated that, in fact, the patient had severe cardiomyopathy. Treatment directed… Show more
“…Only Kubo et al [9] reported a slight AST elevation (65 ± 82 U/L) in patients with a CI ≤ 1.5 L/min/m 2 . However, most other reports (Wiesen et al [18]; Fussell et al [4]) support the findings of our present study, where AST concentrations were shown to be elevated more than 2000-fold, despite a mean CI of 1.9 L/min/m 2 . The main difference of Kubo's report and the other studies are that Kubo described the incidence and severity of liver function abnormalities in patients with congestive heart failure, but in absence of acute decompensation.…”
Section: Discussionsupporting
confidence: 90%
“…Cardiomyopathy as the underlying cause of ALF is rare and only a few case reports are documented in the literature [5,7,8,18]. Cardiac decompensation can initially be undetected, and the usual signs of congestive heart failure may be absent [5,18]. Both, chronic and acute congestive heart failure can lead to hepatic dysfunction [10,17].…”
Congestive heart failure as a cause of acute liver failure is rarely documented with only a few cases.Although the pathophysiology is poorly understood, there is rising evidence, that low cardiac output with consecutive reduction in hepatic blood flow is a main causing factor, rather than hypotension. In the setting of acute liver failure due to congestive heart failure, clinical signs of the latter can be absent, which requires an appropriate diagnostic approach.As a reference center for acute liver failure and liver transplantation we recorded from May 2003 to December 2007 202 admissions with the primary diagnoses acute liver failure. 13/202 was due to congestive heart failure, which was associated with a mortality rate of 54%. Leading cause of death was the underlying heart failure. Asparagine transaminase (AST), bilirubin, and international normalized ratio (INR) did not differ significantly in surviving and deceased patients at admission. Despite both groups had signs of cardiogenic shock, the cardiac index (CI) was significantly higher in the survival group on admission as compared with non-survivors (2.1 L/min/m2 vs. 1.6 L/min/m2, p = 0.04). Central venous - and pulmonary wedge pressure did not differ significantly. Remarkable improvement of liver function was recorded in the group, who recovered from cardiogenic shock.In conclusion, patients with acute liver failure require an appropriate diagnostic approach. Congestive heart failure should always be considered as a possible cause of acute liver failure.
“…Only Kubo et al [9] reported a slight AST elevation (65 ± 82 U/L) in patients with a CI ≤ 1.5 L/min/m 2 . However, most other reports (Wiesen et al [18]; Fussell et al [4]) support the findings of our present study, where AST concentrations were shown to be elevated more than 2000-fold, despite a mean CI of 1.9 L/min/m 2 . The main difference of Kubo's report and the other studies are that Kubo described the incidence and severity of liver function abnormalities in patients with congestive heart failure, but in absence of acute decompensation.…”
Section: Discussionsupporting
confidence: 90%
“…Cardiomyopathy as the underlying cause of ALF is rare and only a few case reports are documented in the literature [5,7,8,18]. Cardiac decompensation can initially be undetected, and the usual signs of congestive heart failure may be absent [5,18]. Both, chronic and acute congestive heart failure can lead to hepatic dysfunction [10,17].…”
Congestive heart failure as a cause of acute liver failure is rarely documented with only a few cases.Although the pathophysiology is poorly understood, there is rising evidence, that low cardiac output with consecutive reduction in hepatic blood flow is a main causing factor, rather than hypotension. In the setting of acute liver failure due to congestive heart failure, clinical signs of the latter can be absent, which requires an appropriate diagnostic approach.As a reference center for acute liver failure and liver transplantation we recorded from May 2003 to December 2007 202 admissions with the primary diagnoses acute liver failure. 13/202 was due to congestive heart failure, which was associated with a mortality rate of 54%. Leading cause of death was the underlying heart failure. Asparagine transaminase (AST), bilirubin, and international normalized ratio (INR) did not differ significantly in surviving and deceased patients at admission. Despite both groups had signs of cardiogenic shock, the cardiac index (CI) was significantly higher in the survival group on admission as compared with non-survivors (2.1 L/min/m2 vs. 1.6 L/min/m2, p = 0.04). Central venous - and pulmonary wedge pressure did not differ significantly. Remarkable improvement of liver function was recorded in the group, who recovered from cardiogenic shock.In conclusion, patients with acute liver failure require an appropriate diagnostic approach. Congestive heart failure should always be considered as a possible cause of acute liver failure.
“…The cardiomyopathy can initially go undetected, and the usual signs of congestive heart failure may be absent (1,2). To our knowledge, no case of fulminant hepatic failure has been reported due to cardiomyopathy developing in the peripartum period.…”
Section: Discussionmentioning
confidence: 90%
“…Cardiomyopathy as the underlying cause of fulminant hepatic failure is rare, with only a few case reports documented in the literature (1)(2)(3)(4). The cardiomyopathy can initially go undetected, and the usual signs of congestive heart failure may be absent (1,2).…”
Section: Discussionmentioning
confidence: 99%
“…In all but the most severe cases, treatment directed at improving cardiac function will result in improvement of the hepatic dysfunction, whether it is simply abnormal liver chemistry tests or fulminant hepatic failure (1)(2)(3)(4). Treatment of peripartum cardiomyopathy is similar to treatment for other causes of nonischemic dilated cardiomyopathy and includes afterload and preload reduction, inotropy, and beta-receptor blockade (6).…”
Congestive heart failure is one of the few treatable causes of fulminant hepatic failure. Congestive heart failure must always be included in the differential diagnosis of fulminant hepatic failure of unknown pathogenesis.
3 Acute liver insufficiency ᭤ J. W. Morgagni (1761) was probably the first to describe acute yellow atrophy of the liver, i. e. hepatic coma. Acute liver failure can be seen as identical to the "acute yellow atrophy" described by K. Rokitansky in 1842. This acute and severe clinical picture was subsequently termed "bilious dyscrasia" (P. J. Horaczek, 1844), "icterus gravis" (C. Ozanam, 1849), "acholia" (F. Th. Frerichs, 1858), "hepatolysis" (R. Ehrmann, 1922), "hepatodystrophy" (G. Herxheimer, 1935) or "liver dystrophy" (R. Böhmig, 1949). The terms "hepatargia" (H. I. Quincke, 1899) and "hepatic coma" were used to denote the final stage, which usually sets in at the end of acute or chronic liver failure. • Acute liver failure in the course of acute viral hepatitis was termed "fulminant hepatitis" by W. Lucke ´et al. (1946), who also defined a subacute form with a less severe course. ( 35)
DefinitionAcute liver failure (ALF) is defined as an acute clinical picture with jaundice due to a most severe disorder in the liver function and/or massive liver cell necrosis which, without any pre-existing liver disease, culminates in hepatic coma (ϭ endogenous coma) within 8 weeks. Potentially, the condition is fully reversible (C. Trey et al., 1970). • In addition, coagulopathy must also be present (D. F. Schafer et al., 1989).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.